Cerevel Therapeutics Holdings, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2020 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Cerevel Therapeutics Holdings, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2020 to Q1 2024.
  • Cerevel Therapeutics Holdings, Inc. Share-based Payment Arrangement, Expense for the quarter ending March 31, 2024 was $20.9M, a 66.2% increase year-over-year.
  • Cerevel Therapeutics Holdings, Inc. Share-based Payment Arrangement, Expense for the twelve months ending March 31, 2024 was $77.8M, a 81.6% increase year-over-year.
  • Cerevel Therapeutics Holdings, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $69.4M, a 79% increase from 2022.
  • Cerevel Therapeutics Holdings, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $38.8M, a 62% increase from 2021.
  • Cerevel Therapeutics Holdings, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $23.9M, a 128% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $77.8M $20.9M +$8.34M +66.2% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $69.4M $25.2M +$14.8M +143% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-27
Q3 2023 $54.6M $17.1M +$7.39M +76.2% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-01
Q2 2023 $47.2M $14.5M +$4.36M +43% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-02
Q1 2023 $42.8M $12.6M +$4.03M +47.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 $38.8M $10.4M +$3.89M +60% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-27
Q3 2022 $34.9M $9.7M +$3.56M +58.1% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-01
Q2 2022 $31.3M $10.1M +$4.96M +95.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-02
Q1 2022 $26.4M $8.56M +$2.42M +39.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-03
Q4 2021 $23.9M $6.49M +$5.83M +889% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-27
Q3 2021 $18.1M $6.13M +$2.66M +76.7% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $15.4M $5.18M +$1.76M +51.4% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-01
Q1 2021 $13.7M $6.14M +$3.17M +107% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $10.5M $656K Oct 1, 2020 Dec 31, 2020 10-K 2023-02-22
Q3 2020 $3.47M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $3.42M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-11
Q1 2020 $2.97M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.